Each batch is independently tested by Janoshik Analytical (Prague)
This means Dihexa was observed to be approximately 10 million times more potent than BDNF in this specific assay for promoting the formation of new dendritic spines
Batch: GF082025009 Key analytical results include: Assay Content: 10.57 mg Identification Retention Time: 0.997 Identification Spectrum: 998 Purity: greater than 99.8 percent Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview FOXO4-DRI is a synthetic research peptide frequently studied in laboratory environments focused on cellular senescence signalling pathways and protein interaction networks
Provides sterile, non-pyrogenic medium for lyophilized peptide reconstitution with preserved bioactivity through bacteriostatic preservation
Speak With a Peptide Therapy Specialist to discuss the latest evidence-based developments and compounding solutions
Ideal candidates for GHK-Cu before and after transformations, based on published research and user reports, include: People in their 30s and early 40s are noticing the first signs of aging People with photoaged or sun-damaged skin People with sensitive, reactive, or rosacea-prone skin People recovering from microneedling, lasers, or peels People dealing with hyperpigmentation, melasma, or acne marks People with early-to-moderate hair thinning People in their 50s and beyond focused on maintenance First-time peptide users looking for a gentle starting point Severe deep wrinkles, advanced sagging, significant volume loss, and fully dead hair follicles wont respond significantly